Pressure Mounts On Zydus Cadila In Q3 As Vaccine Launch Looms

Indian Firm May See Fortunes Change As ZyCov-D And Biosimilars Reach Market

 
• By Chloe Kent
  
Gloved hand holding a blood pressure meter, indicating high blood pressure
Reduced demand for COVID-19 products and dwindling mesalamine sales put Zydus under pressure in Q3 • Source: Alamy

More from Earnings

More from Business